OTC · Drug Manufacturers - Specialty & Generic

BioELife Corp. (LITH) Stock

$0.00 OTC: LITH Healthcare

BioELife Corp. operates in cannabinoid market.

Valuation

MetricValue
Price$0.00
Market Cap$941
P/E Ratio0.00
P/B Ratio0.10
P/S Ratio0.00
EPS (TTM)$-0.22
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-598.11%
ROA-16.48%
ROCE22.68%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.86
Current Ratio0.54

Annual Financials (USD)

Metric20142015201620172018
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$-0.44$-0.04$-0.09$-0.10$-0.13
Op Margin

Balance Sheet (USD)

Metric20142015201620172018
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20142015201620172018
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-3.75
FCF Yield-8149.95%
Quick Ratio0.27
Interest Coverage-0.89
Return 1Y0.00%
Return 3Y-80.00%
Return 5Y

Ownership

Insiders Held66.49%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMHDHLK Biotech Holding Group, Inc. $0.00 $925 0.00%
CFRXQContraFect Corp. $0.00 0.00 $107 0.00%
DMKPQDMK Pharmaceuticals Corporation $0.00 0.00 $1010 0.00%
EFTReFFECTOR Therapeutics, Inc. $0.00 0.00 $2352 0.00%
IMVIFIMV Inc. $0.00 -0.18 $23423 0.00%

About BioELife Corp.

BioELife Corp. operates in cannabinoid market. It offers cannabinoid products, such as combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls, and flowers. The company was formerly known as US Lithium Corp. and changed its name to BioELife Corp. in March 2020. The company was founded in 2006 and is based in Seal Beach, California.

BioELife Corp. (LITH) stock trades at $0.00 with a market capitalization of $941. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.10, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, BioELife Corp. generates a return on equity (ROE) of -598.11%, return on capital employed of 22.68%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.bioelife.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides